Company has announced that it has launch of a new platform for immuno-oncology research.

Company has unveiled its VSO® LowPro Miniature Valve proportional valve for controlling the flow rate of inert gases in medical equipment.

Company has launched its new microscope combined high-performance imaging capabilities with ease to use in such fields as cell biology, cancer research and stem cell research.

Company has announced the commercial availability of new In Vitro Diagnostic test for non-squamous non-small cell lung cancer.

Company has announced that the Tews Laboratory uses an UltraMicroscope for research into the molecular mechanisms of tumor invasion and enhanced imaging of cells.

Company has announced that the range of primary human cancer cells obtained directly from a variety tumor types, including breast, colon and prostate.

Company has announced the launch of its new LabChip® NGS 3K assay for advanced genomics and cancer research, drug development, and next generation sequencing.

Company has announced that the Migraine Medical Device is a preferred treatment for migraine prevention.

Company has announced that the RayStation 5 has been released for new perspective treatment planning and clinical use.

Study describes high-throughput compatible screening assay using 3D tumor microtissue models to classify efficacy, toxicity, and mechanism of action for compounds in NIH Oncology Library.